Chao Huang
Presidente presso Xi'an Lijun Pharmaceutical Co., Ltd.
Profilo
Chao Huang is currently the Director & General Manager at Xi'an Lijun Pharmaceutical Co., Ltd.
since 2011.
He is also a Director at Prime United Industries Ltd.
Mr. Huang previously worked as an Executive Director at SSY Group Ltd.
Mr. Huang holds an MBA from Hong Kong Metropolitan University, which he obtained in 2002.
Posizioni attive di Chao Huang
Società | Posizione | Inizio |
---|---|---|
Prime United Industries Ltd.
Prime United Industries Ltd. Financial ConglomeratesFinance Prime United Industries Ltd. operates as an investment holding There is no available country named vg company. | Direttore/Membro del Consiglio | 25/03/2010 |
Xi'an Lijun Pharmaceutical Co., Ltd.
Xi'an Lijun Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Part of Prime United Industries Ltd., Xi'an Lijun Pharmaceutical Co., Ltd. is a Chinese company that manufactures and distributes pharmaceutical products. The company is based in Xian, China. Xi'an Lijun Pharmaceutical Co. was acquired by United Investments Group Ltd. from SSY Group Ltd. on October 31, 2014 for $99.61 million. | Presidente | 09/09/2011 |
Precedenti posizioni note di Chao Huang
Società | Posizione | Fine |
---|---|---|
SSY GROUP LIMITED | Direttore/Membro del Consiglio | - |
Formazione di Chao Huang
Hong Kong Metropolitan University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
SSY GROUP LIMITED | Health Technology |
Aziende private | 2 |
---|---|
Prime United Industries Ltd.
Prime United Industries Ltd. Financial ConglomeratesFinance Prime United Industries Ltd. operates as an investment holding There is no available country named vg company. | Finance |
Xi'an Lijun Pharmaceutical Co., Ltd.
Xi'an Lijun Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Part of Prime United Industries Ltd., Xi'an Lijun Pharmaceutical Co., Ltd. is a Chinese company that manufactures and distributes pharmaceutical products. The company is based in Xian, China. Xi'an Lijun Pharmaceutical Co. was acquired by United Investments Group Ltd. from SSY Group Ltd. on October 31, 2014 for $99.61 million. | Health Technology |
- Borsa valori
- Insiders
- Chao Huang